268 related articles for article (PubMed ID: 29072684)
1. PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.
Du H; Chen Y; Hou X; Huang Y; Wei X; Yu X; Feng S; Wu Y; Zhan M; Shi X; Lin S; Lu L; Yuan S; Sun L
Cell Death Dis; 2017 Oct; 8(10):e3143. PubMed ID: 29072684
[TBL] [Abstract][Full Text] [Related]
2. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
3. PLOD2 in cancer research.
Du H; Pang M; Hou X; Yuan S; Sun L
Biomed Pharmacother; 2017 Jun; 90():670-676. PubMed ID: 28415047
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.
Song Y; Zheng S; Wang J; Long H; Fang L; Wang G; Li Z; Que T; Liu Y; Li Y; Zhang X; Fang W; Qi S
Oncotarget; 2017 Jun; 8(26):41947-41962. PubMed ID: 28410212
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
6. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling.
Wei X; Li S; He J; Du H; Liu Y; Yu W; Hu H; Han L; Wang C; Li H; Shi X; Zhan M; Lu L; Yuan S; Sun L
Cell Commun Signal; 2019 Jun; 17(1):58. PubMed ID: 31170987
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
[TBL] [Abstract][Full Text] [Related]
8. PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway.
Lan J; Zhang S; Zheng L; Long X; Chen J; Liu X; Zhou M; Zhou J
Cancer Sci; 2023 Aug; 114(8):3190-3202. PubMed ID: 37227305
[TBL] [Abstract][Full Text] [Related]
9. A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1.
Rosell-García T; Palomo-Álvarez O; Rodríguez-Pascual F
J Biol Chem; 2019 Sep; 294(39):14308-14318. PubMed ID: 31391253
[TBL] [Abstract][Full Text] [Related]
10. DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment.
He J; Wei X; Li S; Quan X; Li R; Du H; Yuan S; Sun L
Phytomedicine; 2019 Jun; 59():152778. PubMed ID: 31005809
[TBL] [Abstract][Full Text] [Related]
11. Role of transcription factor FOXA1 in non‑small cell lung cancer.
Li J; Zhang S; Zhu L; Ma S
Mol Med Rep; 2018 Jan; 17(1):509-521. PubMed ID: 29115441
[TBL] [Abstract][Full Text] [Related]
12. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis].
Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860
[No Abstract] [Full Text] [Related]
13. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis.
Eisinger-Mathason TS; Zhang M; Qiu Q; Skuli N; Nakazawa MS; Karakasheva T; Mucaj V; Shay JE; Stangenberg L; Sadri N; Puré E; Yoon SS; Kirsch DG; Simon MC
Cancer Discov; 2013 Oct; 3(10):1190-205. PubMed ID: 23906982
[TBL] [Abstract][Full Text] [Related]
15. Procollagen Lysyl Hydroxylase 2 Expression Is Regulated by an Alternative Downstream Transforming Growth Factor β-1 Activation Mechanism.
Gjaltema RAF; de Rond S; Rots MG; Bank RA
J Biol Chem; 2015 Nov; 290(47):28465-28476. PubMed ID: 26432637
[TBL] [Abstract][Full Text] [Related]
16. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
18. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
19. POM121 promotes proliferation and metastasis in non-small-cell lung cancer through TGF-β/SMAD and PI3K/AKT pathways.
Guan L; Zhang L; Wang T; Jia L; Zhang N; Yan H; Zhao K
Cancer Biomark; 2021; 32(3):293-302. PubMed ID: 34151840
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of PLOD2 induced osimertinib resistance in non-small cell lung cancer HCC827 cells].
Kang XH; Wang K; Wang Y; Zhao HK; Zhang J; Zhao KL; Miao ZH; Xu ZY; Cao F; Gong YB
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):210-215. PubMed ID: 32252199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
